121 related articles for article (PubMed ID: 10665286)
1. [Parameters of blood proteinase inhibitor balance and hyperlipoproteinemia in patients with proliferative diabetic retinopathy with vitreous hemorrhage].
Chesnokova NB; Kuznetsova TP; Davydova GA; Grigor'ev AV
Vestn Oftalmol; 1999; 115(6):29-32. PubMed ID: 10665286
[TBL] [Abstract][Full Text] [Related]
2. [Hyperlipoproteinemias and proteinase inhibitor balance in patients with proliferative diabetic retinopathy with solid exudates in retina].
Chesnokova NB; Kuznetsova TP; Davydova GA; Grigor'ev AV
Vestn Oftalmol; 1999; 115(1):14-6. PubMed ID: 10207312
[TBL] [Abstract][Full Text] [Related]
3. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
Adamiec J; Oficjalska-Młyńczak J
Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
[TBL] [Abstract][Full Text] [Related]
4. [Proteinases inhibitors in sera of diabetic patients with non-proliferative retinopathy].
Skopiński P; Duda-Król B; Lipińska A; Sommer E; Borowska A; Filewska M; Szaflik J; Skopińska-Rózewska E; Struzik E
Klin Oczna; 2004; 106(3 Suppl):424-6. PubMed ID: 15636223
[TBL] [Abstract][Full Text] [Related]
5. High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins.
Liinamaa MJ; Savolainen MJ
Ann Med; 2008; 40(3):209-14. PubMed ID: 18382886
[TBL] [Abstract][Full Text] [Related]
6. Coagulation factors of contact phase of haemostasis are normal in well-controlled type-I diabetic patients despite presence of diabetic retinopathy.
Watzke H; Schernthaner G; Schnack C; Schwarz HP; Prskavec F; Freyler H
Diabetes Res; 1988 Apr; 7(4):197-200. PubMed ID: 3402169
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
Gustavsson C; Agardh E; Bengtsson B; Agardh CD
J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
[TBL] [Abstract][Full Text] [Related]
8. Does cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease?
Banerjee S; Denniston AK; Gibson JM; Dodson PM
Eye (Lond); 2004 Aug; 18(8):821-5. PubMed ID: 14976546
[TBL] [Abstract][Full Text] [Related]
9. [Activities of trypsin-like serine proteases and their inhibitors in blood and subretinal fluid of patients with different stages of proliferative vitreoretinopathy in rhegmatogenous retinal detachment].
Katsnel'son LA; Chesnokova NB; Antelava ND
Vestn Oftalmol; 2000; 116(1):24-6. PubMed ID: 10741259
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of vitreous proteins in proliferative diabetic retinopathy.
Kim SJ; Kim S; Park J; Lee HK; Park KS; Yu HG; Kim Y
Curr Eye Res; 2006 Mar; 31(3):231-40. PubMed ID: 16531280
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
Yang CM; Yeh PT; Yang CH
Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
[TBL] [Abstract][Full Text] [Related]
13. Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy.
Jacqueminet S; Ben Abdesselam O; Chapman MJ; Nicolay N; Foglietti MJ; Grimaldi A; Beaudeux JL
Clin Chim Acta; 2006 May; 367(1-2):103-7. PubMed ID: 16426593
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of adrenomedullin, a vasoactive peptide, in type 2 diabetic patients with and without retinopathy.
Caliumi C; Balducci S; Petramala L; Cotesta D; Zinnamosca L; Cianci R; Di Donato D; Vingolo EM; Fallucca F; Letizia C
Minerva Endocrinol; 2007 Jun; 32(2):73-8. PubMed ID: 17557032
[TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacy of eiconol in patients with diabetic retinopathy].
Sorokin EL; Smoliakova GP; Bachaldin IL
Vestn Oftalmol; 1997; 113(4):37-9. PubMed ID: 9381643
[TBL] [Abstract][Full Text] [Related]
16. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA
Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767
[TBL] [Abstract][Full Text] [Related]
17. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
18. [Cryotherapy of vitreous hemorrhage in diabetic retinopathy].
Lenkiewicz E; Stankiewicz A; Ejchartowa I; Zywalewski B
Klin Oczna; 1989; 91(7-9):195-6. PubMed ID: 2638443
[TBL] [Abstract][Full Text] [Related]
19. Blood antioxidant parameters in patients with diabetic retinopathy.
Siemianowicz K; Gminski J; Telega A; Wójcik A; Posielezna B; Grabowska-Bochenek R; Francuz T
Int J Mol Med; 2004 Sep; 14(3):433-7. PubMed ID: 15289896
[TBL] [Abstract][Full Text] [Related]
20. [Character of changes in indicators of proteinase and proteinase inhibitor activity in gastroenterological pathology in children].
Dovgun OB; Tebloeva LT; Shumeĭko NK; Rudenskaia GN
Vopr Med Khim; 1998; 44(3):282-7. PubMed ID: 9703629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
